跳至主要内容
临床试验/NCT06125444
NCT06125444招募中不适用

IImpact of Hyperuricemia on Psoriatic Arthritis

University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 242 人开始时间: 2020年8月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
242
试验地点
1
主要终点
Retrospectively determine the impact of hyperuricemia on the response to psoriatic arthritis treatments: inventory of the latest treatments in progress and the response to treatment according to the treating rheumatologist

研究概览

简要总结

Psoriatic arthritis and gout (linked to hyperuricemia) are two rheumatisms well known to rheumatologists. There are epidemiological and physiopathological arguments in favor of a non-fortuitous link between these two rheumatisms, which to date has not been established. There is currently no recommendation to treat hyperuricaemia without an episode of gout attack. We hypothesize that there is a link between hyperuricemia and severity of rheumatism. This would ultimately modify the therapeutic management of hyperuricemic patients followed for psoriatic arthritis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Retrospectively determine the impact of hyperuricemia on the response to psoriatic arthritis treatments: inventory of the latest treatments in progress and the response to treatment according to the treating rheumatologist

时间窗: Files analysed retrospectively from January 01, 2009 to December 31, 2019 will be examined

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Impact of Hyperuricemia on Psoriatic Arthritis | 临床试验